Nitrostat

(Nitroglycerin)

ApprovedSmall molecule

Nitroglycerin is used to relieve chest pain (angina) by relaxing blood vessels and improving blood flow to the heart. It can also be used to prevent chest pain before physical activity or stressful situations.[2] Nitrostat is currently approved and in use across 52 indications[4].[1]

Nitrostat is one of 1009 small molecule programs targeting Coronary Artery Disease. It is currently in Approved.

Indications

Total Trials

Active Trials

1,008

Competitors

FDA Applications

NDA/BLA/ANDA regulatory filings

Patents

Pipeline

Status by Indication[4][1]

Indication

Coronary Artery DiseaseActive, not recruiting

Familial Hemiplegic MigraineActive, not recruiting

Cardiovascular DiseaseActive, not recruiting

Ischemia Reperfusion InjuryApproved

Raynaud DiseaseApproved

Migraine DisorderActive, not recruiting

Erectile DysfunctionApproved

HemorrhoidActive, not recruiting

Acute Respiratory FailureNot yet recruiting

Anal FissureActive, not recruiting

Coronary Artery DiseasePhase 2

Active, not recruiting

Familial Hemiplegic MigrainePreclinical

Active, not recruiting

Cardiovascular DiseaseApproved

Active, not recruiting

Ischemia Reperfusion InjuryApproved

Approved

Raynaud DiseaseApproved

Approved

Migraine DisorderPreclinical

Active, not recruiting

Erectile DysfunctionApproved

Approved

HemorrhoidApproved

Active, not recruiting

Acute Respiratory FailurePreclinical

Not yet recruiting

Anal FissurePhase 3

Active, not recruiting

Showing 10 of 49 indications

Competition

Competitive Landscape

1931 competitors in COVID-19

#DrugCompanyPhaseTrials

Nitrostat

VViatris Specialty LLC

Approved

1 2

Spikevax

Moderna

Preclinical

21 3

Biaxin

AbbVie

Preclinical

2 4

Singulair

AstraZeneca

Preclinical

1 5

Stivarga

Bayer

Preclinical

1 6

Low-Molecular-Weight Heparin

Daiichi Sankyo

Preclinical

3 7

SARS-COV-2 VACCINE

Moderna

Preclinical

2 8

Orap

Teva

Preclinical

1 9

Calcium

Eli Lilly

Preclinical

—10

Biological Data

UUniversity Hospital, Bordeaux

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2026

Phase 1Active, not recruiting

Hypertension

NCT02425566

Q4 2026

Recruiting

Hypotensive Anesthesia

NCT06259760

Q2 2027

Phase 1Not yet recruiting

Coronary Artery Disease

NCT07431294

Q3 2027

PreclinicalNot yet recruiting

Acute Respiratory Failure

NCT07603037

Post-ApprovalRecruiting

Pancreatitis

NCT07083063

Clinical

Trials by Indication[1]

Hypertension5 trials

Role of Sympathetic Activity and Splanchnic Capacitance in Hypertension

Active, not recruiting·VVanderbilt University·Phase 1·NCT02425566·12 enrolled

Nitroglycerine Versus Dexmedetomidine Infusion in Intraoperative Management of Uncontrolled Hypertension

Completed·NNational Cancer Institute, Egypt··NCT04953156·77 enrolled

Clevidipine in the Perioperative Treatment of Hypertension (ECLIPSE-NTG)

Completed· Novartis logo

Novartis·Phase 3·NCT00093886·629 enrolled

Show 2 more trials

HaemoDYNAMICs in Primary and Secondary Hypertension

Unknown status·TTampere University··NCT01742702·2,000 enrolled

Treatment of Supine Hypertension in Autonomic Failure

Completed·VVanderbilt University·Phase 1·NCT00223717·152 enrolled

Coronary Artery Disease4 trials

Vericiguat Drug-drug Interaction With Nitroglycerin in Stable Coronary Artery Disease Patients

Completed· Bayer logo

Bayer·Phase 1·NCT02617550·36 enrolled

Effect of Nitric Oxide Donor on Endothelial Progenitor Cells in Patients With Coronary Artery Disease

Completed·NNational Heart, Lung, and Blood Institute (NHLBI)·Phase 2·NCT00090558·30 enrolled

PericOronary INflammaTion in Non-Obstructive Coronary Artery Disease

Terminated·NNYU Langone Health··NCT05031520·32 enrolled

Show 1 more trial

A Randomized, Placebo-controlled, Single Blind Drug-drug Interaction Study to Investigate the Influence of 0.4 mg Nitroglycerin Spray on the Safety, Tolerability and Pharmacodynamic Effects of Nurandociguat in Participants With Stable Coronary Artery Disease.

Not yet recruiting· Bayer logo

Bayer·Phase 1·NCT07431294·36 enrolled

Non-Small Cell Lung Cancer3 trials

Paclitaxel and Carboplatin With or Without Nitroglycerin in Treating Patients With Previously Untreated Stage III or Stage IV Non-Small Cell Lung Cancer

Unknown status·KKyoto University·Phase 2·NCT00616031·150 enrolled

Concurrent Chemotherapy and Radiotherapy With Nitroglycerin in Patients With Locally Advanced Non-Small Cell Lung Cancer

Unknown status·NNational Institute of Cancerología·Phase 2·NCT00886405·40 enrolled

Nitroglycerin in Non-small Cell Lung Cancer

Terminated·MMaastricht Radiation Oncology·Phase 2·NCT01210378·47 enrolled

Prevention3 trials

A Study of a Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon

Unknown status·MMediQuest Therapeutics·Phase 3·NCT00577304·200 enrolled

Trial of IV NTG for CD After Second Stage Arrest for the Prevention of Uterine Extension

Completed·UUniversity of California, San Francisco·Phase 4·NCT02265965·18 enrolled

Topical Nitroglycerine for Prevention of Radial Artery Spasm

Completed·UUniversity of Medicine and Pharmacy "Victor Babes" Timisoara·Phase 3·NCT06912139·100 enrolled

Occlusion3 trials

Intraarterial Nitroglycerin Versus Nicardipine and Radial Artery Occlusion

Completed·HHermina Heart Center Kemayoran·Phase 3·NCT03622060·600 enrolled

Subcutaneous Nitroglycerin to Prevent Radial Artery Occlusion in Children

Completed·SSeoul National University Hospital·N/A·NCT05443061·200 enrolled

Topical Nitroglycerin To Prevent Radial Artery Occlusion After Transradial Access: NTP-RAO Trial

Unknown status·TTotal Cardiovascular Solutions·Phase 3·NCT02413268·2,400 enrolled

57 more indications

Heart Failure3 trials

Assessment of Biomarkers and Cardiorenal Syndrome in Acute Decompensated Heart Failure With Vasodilator Therapy

Completed·WWestern University of Health Sciences·Phase 4·NCT00842023·89 enrolled

A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function

Completed· Bristol-Myers Squibb logo

Bristol-Myers Squibb·Phase 2·NCT03357731·49 enrolled

Evaluating the Effects of Nitroglycerin on Heart Function and Urinary Output in Patients With Acute Heart Failure

Completed·—·Phase 4·NCT06682260·21 enrolled

MPA2 trials

MQX-503 vs Nitroglycerin Ointment: A Pharmacokinetic Comparison in Normal Subjects

Completed·MMediQuest Therapeutics·Phase 1·NCT00513994·6 enrolled

Comparing of Sesame Oil, Nitroglycerin Ointment, and Aloe Vera Gel

Not yet recruiting·UUniversity of Basrah·Phase 2·NCT07346677·190 enrolled

Mastectomy2 trials

The Effect of Nitroglycerin Ointment, Fluorescent Angiography, and Incisional Negative Pressure Wound Therapy on Mastectomy Skin Flap Perfusion-Related Problems

Terminated·WWake Forest University Health Sciences·Phase 2/3·NCT03716050·17 enrolled

Effect of Nitroglycerin Ointment on Mastectomy Flap Necrosis

Completed·UUniversity of British Columbia·N/A·NCT01608880·154 enrolled

Efficacy2 trials

Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients Undergoing Primary PCI

Unknown status·RRenJi Hospital·Phase 4·NCT03252665·600 enrolled

Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients With CSFP

Completed·RRenJi Hospital·Phase 4·NCT03296670·57 enrolled

Endothelial Function2 trials

Effect of Antioxidants on Ocular Blood Flow, Endothelial Function, and Cytokine Levels in LPS Induced Inflammatory Model in Humans.

Completed·MMedical University of Vienna·Phase 4·NCT00431691·22 enrolled

Does Thiazolidinedione Therapy Improve Endothelial Function and Preserve Renal Function

Terminated·MMayo Clinic·N/A·NCT00586261·36 enrolled

Migraine2 trials

Habituation of the Nociceptive Blink Reflex in Experimentally Induced Migraine Attack

Unknown status·IIRCCS National Neurological Institute "C. Mondino" Foundation·N/A·NCT05718310·22 enrolled

Study of the Glymphatic System in Migraine

Recruiting·IIRCCS San Raffaele··NCT05907655·50 enrolled

Hypotensive Anesthesia2 trials

AKI Risk Factors Analysis After Intentional Hypotensive Anesthesia

Recruiting·KKaohsiung Medical University Chung-Ho Memorial Hospital··NCT06259760·50 enrolled

Anesthetic Advantages of Dexmedetomidine for Hypotensive Anesthesia

Completed·MMahidol University·N/A·NCT02083055·40 enrolled

Microcirculation2 trials

Intravenous NTG to Preserve Gastric Microcirculation During Gastric Tube Reconstruction

Completed·EErasmus Medical Center·N/A·NCT00335010·32 enrolled

Physiologic Effect of Topical Nitroglycerin on Microcirculation Capacity in Patients With Circulatory Shock.

Completed·UUniversity of Pennsylvania··NCT05102734·44 enrolled

Clinical Trial2 trials

Randomized Clinical Trial of Non-Surgical Reperfusion of the Coronary Arteries

Completed·NNational Heart, Lung, and Blood Institute (NHLBI)·Phase 3·NCT00000503

Randomized Clinical Trial Comparing Transradial Catheterization With or Without Spasmolytic Drugs

Completed·IInstituto de Cardiologia de Santa Catarina·Phase 3·NCT02343276·328 enrolled

Angina Pectoris2 trials

Efficacy and Safety of Xueshuanxinmaining Tablet for the Treatment of Stable Angina Pectoris

Unknown status·GGuang'anmen Hospital of China Academy of Chinese Medical Sciences·Phase 4·NCT04270279·120 enrolled

Efficacy and Safety of Yangxin Shengmai Granules for the Treatment of Stable Angina Pectoris

Unknown status·GGuang'anmen Hospital of China Academy of Chinese Medical Sciences·Phase 4·NCT04270071·80 enrolled

Treatment1 trial

Dose Response Study of a Topical Formulation of Nitroglycerin for the Treatment of Raynaud's Phenomenon

Completed·MMediQuest Therapeutics·Phase 2·NCT00480753·15 enrolled

Echocardiography1 trial

Application of Intraoperative Transesophageal Echocardiography Imaging of Vein and CLCVP in Early Prediction and Intervention CSA-AKI

Completed·NNanjing First Hospital, Nanjing Medical University·N/A·NCT05682716·137 enrolled

Hemodynamic1 trial

Ocular Hemodynamic Effects of Nitrovasodilators in Healthy Subjects

Completed·MMedical University of Vienna·N/A·NCT00810381·14 enrolled

Pulmonary Hypertension1 trial

PGI2 Versus Nitroglycerine for Management of Pulmonary Hypertension After Valve Surgeries

Unknown status·—·Phase 1·NCT04594629·120 enrolled

Magnesium Sulfate1 trial

Comparison Between Pregabalin and Magnesium Sulfate in Hypotensive Anaesthesia

Unknown status·MMinia University·Phase 1/2·NCT05442931·60 enrolled

Cardiopulmonary Bypass1 trial

Esmolol or Nitroglycerin Infusion for Blood Pressure Control Prior to Cardiopulmonary Bypass (CPB) in Cardiac Surgery

Completed·LLoma Linda University·N/A·NCT01212874·70 enrolled

Trial1 trial

Phosphate Lowering in CKD Trial

Completed·VVA Office of Research and Development·Phase 4·NCT02209636·66 enrolled

Retinoblastoma1 trial

Nitroglycerin for Intra-arterial Chemotherapy in Pediatric Retinoblastoma.

Unknown status·SSeoul National University Hospital·N/A·NCT04564521·36 enrolled

Sinus Surgery1 trial

Comparison Between Two Drugs (Propofol and Nitroglycerin as a Hypotensive Agents During Endoscopic Sinus Surgery

Terminated·—·Phase 1/2·NCT04220281·40 enrolled

Vasodilation1 trial

Evidence of Spreading Vasodilation in Human Gingiva

Completed·SSemmelweis University·N/A·NCT03605095·40 enrolled

Bone Defects1 trial

Effect of Nitroglycerin Hydrogel on Repairing Critical Bone Defects

Not yet recruiting·MMinia University·N/A·NCT06925763·33 enrolled

Pulmonary Edema1 trial

High Versus Low Dose Nitroglycerin in Acute Pulmonary Edema

Unknown status·—·Phase 2/3·NCT06107465·60 enrolled

Age1 trial

Effects of Sublingual and Transdermal Administration of Nitroglycerin for Coronary CT Angiography on Image Quality

Completed·MMassachusetts General Hospital·Phase 4·NCT02961946·198 enrolled

Anemia1 trial

Effects of Nitric Oxide and Nitroglycerin in Patients With Sickle Cell Anemia

Completed·NNational Institutes of Health Clinical Center (CC)·Phase 2·NCT00001716·58 enrolled

Hypotension1 trial

Effects of Nitroglycerin Versus Labetalol on Tissue Perfusion During Deliberate Hypotension

Completed·—·Phase 4·NCT03809065·40 enrolled

Cognitive Functions1 trial

Changes in Cerebral Oxygenation and Cognitive Functions

Completed·—··NCT04948957·40 enrolled

Coronary Atherosclerosis1 trial

Effect of Evolocumab on Coronary Atherosclerosis

Completed·—·Phase 3·NCT03689946·55 enrolled

Infertility1 trial

Effect of Nitric Oxide Donors on Uterine and Subendometrial Blood Flow in Patients With Unexplained Infertility

Completed·—·N/A·NCT03481582·60 enrolled

Acute Myocardial Infarction1 trial

Effects of Different Vasodilators on Coronary No-reflow During primAry percuTaneous Coronary intErvention in Patients With Acute Myocardial Infarction

Completed·FFudan University·Phase 4·NCT00712894·102 enrolled

Ischemic stroke1 trial

Perfusion and Antihypertensive Therapy in Acute Ischemic Stroke

Completed·UUniversity of Alberta·Phase 2·NCT02327793·65 enrolled

Spinal Surgery1 trial

Correlation Analysis of the Effects of Management Pressure Goals and Control Volume Goals in Patients in Spinal Surgery

Unknown status·LLiang Bing·N/A·NCT03917004·160 enrolled

Oxytocin1 trial

The Relaxant Effect of Nitroglycerin on Oxytocin Desensitized Human Myometrium

Completed·SSamuel Lunenfeld Research Institute, Mount Sinai Hospital·N/A·NCT03408054·17 enrolled

COVID-191 trial

Efficacy of Inhaled Nitroglycerin in Moderate to Critically Ill COVID-19 Patients

Completed·—·N/A·NCT04686760·278 enrolled

Pediatric1 trial

Subcutaneous Nitroglycerin for Pediatric Radial Artery Cannulation

Completed·SSeoul National University Hospital·N/A·NCT03849183·116 enrolled

Hypoxia1 trial

The Mechanisms of Diameter Changes in Retinal Vessels During Hypoxia

Completed·UUniversity of Aarhus·N/A·NCT02059018·20 enrolled

Cardiac Surgery1 trial

Nitroglycerin Infusion During Cardiac Surgery

Completed·TTri-Service General Hospital·N/A·NCT01901419·80 enrolled

Postmenopausal Women1 trial

Nitroglycerin Ointment for Preventing Bone Loss in Postmenopausal Women

Completed·NNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)·Phase 3·NCT00043719·200 enrolled

Arteriovenous Fistula1 trial

Effects of Exercise and Improved Nitric Oxide Bioavailability on Arteriovenous Fistula Maturation

Terminated·—·N/A·NCT02164318·11 enrolled

Pancreatitis1 trial

Precise Endoscopic Application of Nitroglycerin in Preventing Post-ERCP Pancreatitis

Recruiting·NNational Cheng-Kung University Hospital·Phase 4·NCT07083063·440 enrolled

Coronary Artery Bypass1 trial

The Effect of Intranasally Administered Nitroglycerin on Hemodynamic Response to Laryngoscopy and Intubation Among Patients Undergoing Coronary Artery Bypass Grafting (CABG) Surgery

Completed·MMuhammad Aamir Latif·N/A·NCT06637956·58 enrolled

Hemorrhoid1 trial

Nitroglycerin Ointment for Pain Relief After Endoscopic Hemorrhoid Band Ligation

Not yet recruiting·YYing Zhu·Phase 4·NCT07391501·68 enrolled

Atherosclerosis1 trial

Study to Evaluate Subclinical Atherosclerosis (an Early Sign of Heart Disease) in Healthy Adult Immigrant Asian Indians

Withdrawn·NNorthwell Health·N/A·NCT01104597

Ultrasound1 trial

Ultrasound Evaluation of Lower Extremity Arteries After Topical Nitroglycerin Administration

Unknown status·DDeborah Heart and Lung Center·Phase 1·NCT04155476·80 enrolled

Flushing1 trial

Flushing Reduction Associated With Nitrates

Completed·—·Phase 2·NCT02714205·141 enrolled

Nephropathy1 trial

Contrast Nephropathy and Nitrates

Completed·MMt. Sinai Medical Center, Miami·Phase 4·NCT01999517·122 enrolled

POI1 trial

Topical Nitrates for Myofascial Trigger Points

Completed·GGF Strong Rehabilitation Centre·N/A·NCT01675700·10 enrolled

Dilation1 trial

Safety and Tolerability of Nitro for Radial Artery Dilation

Unknown status·TThomas Jefferson University·Phase 1·NCT05239013·20 enrolled

Absorption1 trial

Absorption and Pharmacokinetics of Nitroglycerin to a New Formulation

Unknown status·KKolding Sygehus·Phase 4·NCT03777605·10 enrolled

Lidocaine1 trial

Radial Artery Dilation Study: The Effect of Topical Administration of Nitroglycerin and Lidocaine Versus Lidocaine Alone of the Radial Artery Diameter

Completed·UUniversity of California, San Francisco·Phase 1·NCT00686231·19 enrolled

Preterm Labor1 trial

Transdermal Nitroglycerin and Nifedipine in Preterm Labor

Completed·SShiraz University of Medical Sciences·Phase 4·NCT02583633·112 enrolled

Hemorrhagic Shock1 trial

Use of Nitroglycerine to Improve Signs of Poor Peripheral Perfusion in Patients With Traumatic Hemorrhagic Shock

Unknown status·—·Phase 2·NCT03235921·100 enrolled

Phlebitis1 trial

Ointment Therapy and Prevention of Cannulation-Induced Superficial Phlebitis

Unknown status·KKomar University of Science and Technology·Phase 1/2·NCT04685031·110 enrolled

Orthognathic Surgery1 trial

A Cohort Prospective Study of Predictors Influencing the Quality of Visualization of the Operating Field During Orthognathic Surgery

Enrolling by invitation·SState Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia··NCT05814991·100 enrolled

Anal fissure1 trial

The Use of Platelet-rich Plasma in the Treatment of Chronic Anal Fissure

Completed·—·Phase 3·NCT05837403·460 enrolled

Acute Respiratory Failure1 trial

Effect of Nicardipine and Nitroglycerin on the Ventilation-Perfusion Ratio in Patients With Acute Respiratory Failure Using Electrical Impedance Tomography: A Prospective Pilot Study

Not yet recruiting·FFirst Affiliated Hospital of Wannan Medical College·Preclinical·NCT07603037·12 enrolled

Hepatocellular Carcinoma (HCC)1 trial

Utilizing Parenchymal Blood Volume Imaging to Assess Changes in Hepatocellular Carcinoma Perfusion as Potentiated by Intra-Arterial Nitroglycerin

Not yet recruiting·UUniversity of California, San Francisco·Phase 2·NCT07682454·50 enrolled

Unspecified2 trials

Endothelium Dependent and Non-dependent Vasodilatation in Human Gingiva

Completed·SSemmelweis University·N/A·NCT04918563·24 enrolled

Effects of Nicorandil on Angina Symptoms in Patients With Coronary Slow Flow

Completed·MMashhad University of Medical Sciences·Phase 4·NCT02254252·54 enrolled

Regulatory

FDA Approval Timeline[5]

Jan 1, 1982

NITROSTAT

NDA NDA018588

Jan 1, 1982

NITROGLYCERIN

NDA NDA018531

Jan 5, 1982

NITRO-BID

NDA NDA018621

Jan 19, 1983

NITROL

NDA NDA018774

Jun 16, 1983

TRIDIL

NDA NDA018537

Aug 30, 1983

NITRO IV

NDA NDA018672

Oct 31, 1985

NITROLINGUAL

NDA NDA018705

Dec 29, 1989

NITROGLYCERIN IN DEXTROSE 5%

NDA NDA019970

Apr 4, 1995

NITRO-DUR

NDA NDA020145

Feb 27, 1996

TRANSDERM-NITRO

NDA NDA020144

May 1, 2000

NITROSTAT

NDA NDA021134

Nov 2, 2006

NITROMIST

NDA NDA021780

Jun 21, 2011

RECTIV

NDA NDA021359

Jun 8, 2016

GONITRO

NDA NDA208424

Sources

References

[1]
ClinicalTrials.gov — 87 trial records for Nitroglycerin. U.S. National Library of Medicine, National Institutes of Health.
[2]
MedlinePlus Drug Information — Nitrostat drug information. U.S. National Library of Medicine, National Institutes of Health.
[3]
ChEMBL — Nitroglycerin compound record. European Bioinformatics Institute (EMBL-EBI).
[4]
Open Targets Platform — Drug–disease associations for Nitroglycerin. EMBL-EBI & Wellcome Sanger Institute.
[5]
OpenFDA — FDA approval records (NDA NDA208424). U.S. Food & Drug Administration.
[6]
FDA Orange Book — Patent and exclusivity data for Nitrostat. U.S. Food & Drug Administration.
[7]
SEC EDGAR — Viatris Specialty LLC company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Mechanism of Action: Soluble Guanylate Cyclase Activator[3]
Modality: Small molecule[3]
Highest Phase: Approved[1]
Company: VViatris Specialty LLC

Patent Landscape[6]

Patent Cliff

Mar 12, 2029

Earliest patent expiration — generic entry possible after this date

Patent #Expires

7872049Mar 12, 2029

9101592Mar 11, 2032

Nitrostat

Status by Indication[4][1]

Competitive Landscape

Expected Milestones

Q3 2026

Q4 2026

Q2 2027

Q3 2027

Trials by Indication[1]

Hypertension5 trials

Coronary Artery Disease4 trials

Non-Small Cell Lung Cancer3 trials

Prevention3 trials

Occlusion3 trials

Heart Failure3 trials

MPA2 trials

Mastectomy2 trials

Efficacy2 trials

Endothelial Function2 trials

Migraine2 trials

Hypotensive Anesthesia2 trials

Microcirculation2 trials

Clinical Trial2 trials

Angina Pectoris2 trials

Treatment1 trial

Echocardiography1 trial

Hemodynamic1 trial

Pulmonary Hypertension1 trial

Magnesium Sulfate1 trial

Cardiopulmonary Bypass1 trial

Trial1 trial

Retinoblastoma1 trial

Sinus Surgery1 trial

Vasodilation1 trial

Bone Defects1 trial

Pulmonary Edema1 trial

Age1 trial

Anemia1 trial

Hypotension1 trial

Cognitive Functions1 trial

Coronary Atherosclerosis1 trial

Infertility1 trial

Acute Myocardial Infarction1 trial

Ischemic stroke1 trial

Spinal Surgery1 trial

Oxytocin1 trial

COVID-191 trial

Pediatric1 trial

Hypoxia1 trial

Cardiac Surgery1 trial

Postmenopausal Women1 trial

Arteriovenous Fistula1 trial

Pancreatitis1 trial

Coronary Artery Bypass1 trial

Hemorrhoid1 trial

Atherosclerosis1 trial

Ultrasound1 trial

Flushing1 trial

Nephropathy1 trial

POI1 trial

Dilation1 trial

Absorption1 trial

Lidocaine1 trial

Preterm Labor1 trial

Hemorrhagic Shock1 trial

Phlebitis1 trial

Orthognathic Surgery1 trial

Anal fissure1 trial

Acute Respiratory Failure1 trial

Hepatocellular Carcinoma (HCC)1 trial

Unspecified2 trials

FDA Approval Timeline[5]

References

Drug Info

Quick Facts

Patent Landscape[6]

Related News